Pregled bibliografske jedinice broj: 1226786
Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia
Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia // Neuropsychobiology, 79 (2019), 3; 179-185 doi:10.1159/000504577 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1226786 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vitamin D and Neurotrophin Levels and Their Impact
on the Symptoms of Schizophrenia
Autori
Peitl, Vjekoslav ; Silić, Ante ; Orlović, Ivona ; Vidrih, Branka ; Crnković, Danijel ; Karlović, Dalibor
Izvornik
Neuropsychobiology (0302-282X) 79
(2019), 3;
179-185
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Brain-derived neurotrophic factor ; Nerve growth factor ; Neuregulin-1 ; Schizophrenia ; Vitamin D
Sažetak
Introduction: Vitamin D is involved in brain development and functioning, as well as in regulation of neurotrophic factors. Changes in the expression of those factors are possibly responsible for morphologic abnormalities and symptoms in patients suffering from schizophrenia. Objective: The main goal of this research was to investigate the interrelationship between vitamin D, nerve growth factors (NGF, brain-derived neurotrophic factor [BDNF], and neuregulin-1 [NRG1]), and schizophrenia symptom domains. Methods: This research included 97 inpatients diagnosed with schizophrenia. Schizophrenia symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS). Blood samples were taken in order to analyze concentrations of vitamin D, BDNF, NRG1, and NGF growth factors. The obtained results were used in a multiple regression analysis. Results: The vitamin D concentration positively affected the concentration of NRG1 (F = 8.583, p = 0.005) but not the concentration of other investigated growth factors (BDNF and NGF). The clinical characteristics and symptom domains of schizophrenia seemed to be unaffected by the concentrations of vitamin D, BDNF, and NGF, while the NRG1 concentration significantly affected positive symptom domains of schizophrenia (F = 4.927, p = 0.030). Conclusion: The vitamin D concentration positively affected NRG1 levels but not schizophrenia symptomatology as measured by PANSS. The as- sociation between the two could be intermediated via NRG1.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Hrvatsko katoličko sveučilište, Zagreb
Profili:
Ante Silić
(autor)
Vjekoslav Peitl
(autor)
Ivona Orlović
(autor)
Danijel Crnković
(autor)
Dalibor Karlović
(autor)
Branka Vidrih
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE